Evidence map›Paper›PMID 41893941›Full record

ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2026

Adherence to Hypertension Medications During the First Year of Treatment in Elderly Patients and its Effect on Clinical Outcomes.

Ophir Lavon, Sinan Omri

Abstract read
In one paragraph

Article in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ophir LavonClinical Pharmacology and Toxicology Unit, Carmel Medical Center, Michal St. 7, 3436212, Haifa, Israel. ophir.lavon@technion.ac.il.ORCID http://orcid.org/0000-0001-9681-8517
Sinan OmriClinical Pharmacology and Toxicology Unit, Carmel Medical Center, Michal St. 7, 3436212, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdherence to antihypertensive medications is essential to ensure therapeutic effectiveness. However, the long-term clinical impact of adherence during the first year of treatment in elderly patients remains uncertain.

aimTo evaluate the level of adherence to antihypertensive therapy during the first year following diagnosis in elderly patients and to assess its long-term clinical implications.

methodsThis retrospective cohort study included adult patients aged ≥ 65 years with newly diagnosed essential hypertension. Medication adherence during the first year after diagnosis was assessed using the proportion of days covered (PDC). Clinical outcomes-including myocardial infarction, stroke, and all-cause mortality-were evaluated beyond the first year, with an average follow-up of 108 months. Data were extracted from the electronic medical records of a large community-based healthcare provider.

resultsA total of 2934 patients were included in the analysis. The mean age was 72.4 years, and approximately 60% were women. Among the cohort, 21.3% had a PDC of less than 70%. Adherence above the 70% threshold was significantly associated with a reduced incidence of stroke (HR = 0.59; 95% CI 0.37-0.94; p = 0.028).

conclusionsHigher adherence (≥ 70%) to antihypertensive therapy during the first year of treatment in elderly patients was associated with a significantly lower incidence of stroke in subsequent years. These findings highlight the importance of early adherence and support the need for targeted interventions to promote sustained medication use, even in older populations.

Indexed as

Antihypertensive AgentsBlood PressureHypertensionMedication AdherenceAgedAged, 80 and overAge FactorsFemaleHumansIncidenceMaleMyocardial InfarctionRetrospective StudiesRisk AssessmentRisk FactorsStrokeAntihypertensive AgentsAdherenceElderlyHypertensionMedicationOutcome

Identifiers

PMID41893941
PMCPMC13283169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.